ScreenerHero

STRAP Strategic Partners A/S

CPH · DK · Healthcare · Biotechnology · strategic-partners.dk
690.00DKK-1.43%Mkt Cap: 5.40M $P/E: 22.26

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 202…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap5.40M USD
Enterprise Value1.85M USD
Revenue (TTM)44.28K USD
Gross Profit44.28K USD
Net Income (TTM)-125.12K USD
Revenue/Share7.28 DKK
Last Price690.00 DKK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryDK
SectorHealthcare
IndustryBiotechnology
ISINDK0062502894
Valuation
P/E (Trailing)22.26
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue41.68
P/S123.76
P/B1.50
EPS (TTM)31.00
EPS (Forward)—
52W Range
515.0036% of range998.00
52W High998.00 DKK
52W Low515.00 DKK
Profitability
Gross Margin100.00%
Oper. Margin-927.00%
EBITDA Margin0.00%
Profit Margin-277.99%
ROE-4.67%
ROA-4.40%
Growth
Revenue Growth-4.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-311.11K USD
CapEx (TTM)—
FCF Margin-410.44%
FCF Yield-3.36%
Net Debt-2.41M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio23.55
Quick Ratio23.55
Book Value/Sh465.21 DKK
Cash/Share396.24 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 DKK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateDec 6, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.53.75K
Float4.41K
Insiders68.93%
Institutions4.49%
Technical
SMA 50684.80 (+0.8%)
SMA 200637.59 (+8.2%)
Beta0.29
S&P 52W Chg14.58%
Avg Vol (30d)67
Avg Vol (10d)29
Technical Indicators
RSI (14)57.1
MACD-1.0432
MACD Signal-6.9074
MACD Hist.+5.8641
BB Upper696.65 DKK
BB Middle657.25 DKK
BB Lower617.85 DKK
BB Width11.99%
ATR (14)19.25 DKK
Vol Ratio (20d)0.79x